Free Trial
→ 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (From WealthPress) (Ad) Free RNTX Stock Alerts

Rein Therapeutics (RNTX) SEC Filings & 10K Form

$2.70 +0.02 (+0.75%)
As of 02/21/2025 04:00 PM Eastern
Compare

Recent Rein Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
12/06/2024
3:34 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:35 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Fairey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:38 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:41 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Aivado Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:03 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
4:17 PM		Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
Form SCHEDULE 13G/A
08/22/2024
3:05 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Fairey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:07 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Aivado Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:12 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
4:23 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:29 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 424B5
07/26/2024
3:33 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 424B5
07/26/2024
3:36 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
7:41 AM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form ARS
07/09/2024
7:30 AM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form DEF 14A
07/09/2024
7:36 AM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form DEFA14A
06/17/2024
6:03 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
5:18 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:59 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:58 AM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:19 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Cunningham Timothy M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2024
4:16 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:54 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4/A
05/01/2024
6:15 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
4:24 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 424B5
05/01/2024
4:25 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
4:16 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:40 AM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:54 AM		Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
Form FWP
04/30/2024
2:32 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2024
7:33 AM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-K/A
04/16/2024
4:16 PM		Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
Satter Muneer A (Filed by)
Form SC 13D/A
04/15/2024
4:21 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
4:22 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:15 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4/A
04/10/2024
3:15 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4/A
04/02/2024
5:10 PM		Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Garner Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
3:15 PM		Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form NT 10-K
This Crypto Is Set to Explode in February (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW
03/29/2024
7:03 AM		AILERON THERAPEUTICS INC (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
6:00 AM		AILERON THERAPEUTICS INC (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:06 PM		AILERON THERAPEUTICS INC (Issuer)
Rein Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:14 PM		AILERON THERAPEUTICS INC (Subject)
Rein Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
Form SC 13G
03/01/2024
3:05 PM		AILERON THERAPEUTICS INC (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:05 PM		AILERON THERAPEUTICS INC (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:01 AM		AILERON THERAPEUTICS INC (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RNTX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored